Literature DB >> 14810262

Multilobar pulmonary venous obstruction with pulmonary hypertension; protective arterial lesions in the involved lobes.

J E EDWARDS, H B BURCHELL.   

Abstract

Entities:  

Keywords:  BLOOD PRESSURE, HIGH; PULMONARY VEIN

Mesh:

Year:  1951        PMID: 14810262     DOI: 10.1001/archinte.1951.03810030045004

Source DB:  PubMed          Journal:  AMA Arch Intern Med        ISSN: 0888-2479


× No keyword cloud information.
  11 in total

1.  AUTO-ANTIBODY STUDIES IN INTERSTITIAL PULMONARY FIBROSIS.

Authors:  M TURNER-WARWICK; D DONIACH
Journal:  Br Med J       Date:  1965-04-03

2.  PULMONARY HYPERTENSION DUE TO OBSTRUCTION OF THE INTRAPULMONARY VEINS.

Authors:  P G STOVIN; M J MITCHINSON
Journal:  Thorax       Date:  1965-03       Impact factor: 9.139

3.  Iron incrustation of the pulmonary vessels in patent ductus arteriosus with congenital mitral disease.

Authors:  K W WALTON; D HEATH
Journal:  Br Heart J       Date:  1960-06

4.  The less common forms of pulmonary hypertension.

Authors:  W EVANS
Journal:  Br Heart J       Date:  1959-04

5.  Primary pulmonary hypertension with obstructive venous lesions.

Authors:  D B BREWER; D R HUMPHREYS
Journal:  Br Heart J       Date:  1960-06

6.  [On the bronchial veins and their position between the greater and lesser circulation].

Authors:  J SCHOENMACKERS
Journal:  Arch Kreislaufforsch       Date:  1960-02

7.  The clinico-pathological syndrome produced by co-existing pulmonary arterial and venous hypertension.

Authors:  D HEATH; E V COX; J N HARRIS-JONES
Journal:  Thorax       Date:  1957-12       Impact factor: 9.139

8.  The small pulmonary vessels in mitral stenosis.

Authors:  E W HENRY
Journal:  Br Heart J       Date:  1952-07

9.  Chronic idiopathic pulmonary hilar fibrosis. A clinicopathological entity.

Authors:  M H Yacoub; V C Thompson
Journal:  Thorax       Date:  1971-07       Impact factor: 9.139

10.  Pulmonary veno-occlusive disease.

Authors:  K Weisser; F Wyler; F Gloor
Journal:  Arch Dis Child       Date:  1967-06       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.